Tapewire

Nasdaq · USD

QTRX

Quanterix Corp

Export transactions ↓
Tapewire entity
6649
SEC CIK
0001503274
Parsed reports
711

Last 12 months

Inside the activity.

3 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2026 Filed Jan 6, 2026 22:49 UTC GrantCommon Stock 23,372 $0.00 $0.00
Disclosure

SEC source: 0001698265-26-000001 · primarydocument.xml · nonDerivative · entry 1

Hampton Malcolm Garret · CIK 0001698265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,099

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 70,099 restricted stock units.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:49 UTC GrantCommon Stock 23,372 $0.00 $0.00
Disclosure

SEC source: 0002098803-26-000001 · primarydocument.xml · nonDerivative · entry 1

Sachs Alan Bruce · CIK 0002098803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,099

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 70,099 restricted stock units.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:45 UTC
Mendel ScottDirector
GrantCommon Stock 1,944 $0.00 $0.00
Disclosure

SEC source: 0001515051-26-000001 · primarydocument.xml · nonDerivative · entry 2

Mendel Scott · CIK 0001515051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,053

F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2025.

F2 · balance_after: Includes 47,836 restricted stock units.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:45 UTC
Mendel ScottDirector
GrantCommon Stock 23,372 $0.00 $0.00
Disclosure

SEC source: 0001515051-26-000001 · primarydocument.xml · nonDerivative · entry 1

Mendel Scott · CIK 0001515051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,109

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 47,836 restricted stock units.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:45 UTC
Flynn KarenDirector
GrantCommon Stock 23,372 $0.00 $0.00
Disclosure

SEC source: 0001553599-26-000001 · primarydocument.xml · nonDerivative · entry 1

Flynn Karen · CIK 0001553599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,212

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 35,216 restricted stock units.

Read SEC document
January 02, 2026 Filed Jan 14, 2026 16:01 UTC GrantCommon Stock 23,372 $0.00 $0.00
Disclosure

SEC source: 0001689757-26-000001 · primarydocument.xml · nonDerivative · entry 1

Elliott Jeffrey Thomas · CIK 0001689757 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,792

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 31,402 restricted stock units.

Read SEC document
January 02, 2026 Filed Jan 15, 2026 18:56 UTC GrantCommon Stock 3,974 $0.00 $0.00
Disclosure

SEC source: 0001033876-26-000001 · primarydocument.xml · nonDerivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,253

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third and fourth quarter of 2025.

Read SEC document
January 02, 2026 Filed Jan 15, 2026 17:29 UTC GrantCommon Stock 23,372 $0.00 $0.00
Disclosure

SEC source: 0001279281-26-000001 · primarydocument.xml · nonDerivative · entry 1

Magovcevic-Liebisch Ivana · CIK 0001279281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,607

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 43,607 restricted stock units.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 21:51 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 258 $6.36 $1,640.88
Disclosure

SEC source: 0001867276-26-000001 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508,446

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 761 restricted stock units (RSUs).

F2 · balance_after: Includes 211,362 RSUs.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 20:28 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $7.41 $1,696.89
Disclosure

SEC source: 0001908223-25-000009 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,977

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 777 restricted stock units (RSUs).

F2 · balance_after: Includes 84,652 RSUs.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 20:27 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $7.41 $9,203.22
Disclosure

SEC source: 0001867276-25-000009 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508,704

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 3,722 restricted stock units (RSUs).

F2 · balance_after: Includes 212,123 RSUs

Read SEC document
November 30, 2025 Filed Dec 3, 2025 16:53 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 254 $7.26 $1,844.04
Disclosure

SEC source: 0001867276-25-000008 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 509,946

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 761 restricted stock units (RSUs).

F2 · balance_after: Includes 215,845 RSUs

Read SEC document
November 20, 2025 Filed Nov 25, 2025 00:07 UTC
DONNELLY WILLIAM PDirector · Executive Chair
GrantStock Options (Right to buy) · Derivative 70,091 $0.00 Strike: $5.91 $0.00
Disclosure

SEC source: 0001207928-25-000005 · primarydocument.xml · derivative · entry 1

DONNELLY WILLIAM P · CIK 0001207928 · Director · Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,091

Underlying: Common Stock · 70,091 shares

Expires 2035-11-20

F1 · derivative.exercise_date: The stock options vest monthly over two years in 24 equal installments, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
November 20, 2025 Filed Nov 25, 2025 19:37 UTC GrantCommon Stock 46,727 Not disclosed Not disclosed
Disclosure

SEC source: 0001698265-25-000004 · primarydocument.xml · nonDerivative · entry 1

Hampton Malcolm Garret · CIK 0001698265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,727

F1 · price: Represents the number of shares of common stock issuable on the vesting of restricted stock units ("RSUs"). The RSUs vest as to one-third of the total number of shares on each of November 20, 2026, November 20, 2027 and November 20, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
November 20, 2025 Filed Dec 8, 2025 14:33 UTC GrantCommon Stock 46,727 Not disclosed Not disclosed
Disclosure

SEC source: 0002098803-25-000006 · primarydocument.xml · nonDerivative · entry 1

Sachs Alan Bruce · CIK 0002098803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,727

F1 · price: Represents the number of shares of common stock issuable on the vesting of restricted stock units ("RSUs"). The RSUs vest as to one-third of the total number of shares on each of November 20, 2026, November 20, 2027 and November 20, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
November 15, 2025 Filed Nov 24, 2025 19:52 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $5.78 $1,323.62
Disclosure

SEC source: 0001908223-25-000008 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,206

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 777 restricted stock units (RSUs).

F2 · balance_after: Includes 85,429 RSUs.

Read SEC document
November 15, 2025 Filed Nov 24, 2025 19:51 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $5.74 $7,129.08
Disclosure

SEC source: 0001867276-25-000007 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 510,200

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 2,480 restricted stock units (RSUs).

F2 · balance_after: Includes 216,606 RSUs.

Read SEC document
October 31, 2025 Filed Nov 5, 2025 18:12 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 254 $5.34 $1,356.36
Disclosure

SEC source: 0001867276-25-000006 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 511,442

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 761 restricted stock units (RSUs).

F2 · balance_after: Includes 219,086 RSUs

Read SEC document
October 15, 2025 Filed Oct 18, 2025 01:44 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $5.78 $1,323.62
Disclosure

SEC source: 0001908223-25-000007 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,742

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 777 restricted stock units (RSUs).

F2 · balance_after: Includes 70,893 RSUs.

Read SEC document
October 15, 2025 Filed Oct 18, 2025 01:43 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $5.78 $7,178.76
Disclosure

SEC source: 0001867276-25-000005 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 511,696

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 3,722 restricted stock units (RSUs).

F2 · balance_after: Includes 219,847 RSUs

Read SEC document
October 01, 2025 Filed Oct 4, 2025 00:54 UTC GrantCommon Stock 2,084 $5.54 $11,545.36
Disclosure

SEC source: 0001168581-25-000003 · primarydocument.xml · nonDerivative · entry 1

LAI GOLDMAN MYLA · CIK 0001168581 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,488

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2025.

F3 · balance_after: Includes 24,464 restricted stock units.

Read SEC document
October 01, 2025 Filed Oct 4, 2025 00:54 UTC GrantCommon Stock 5,076 $5.54 $28,121.04
Disclosure

SEC source: 0001207928-25-000004 · primarydocument.xml · nonDerivative · entry 1

DONNELLY WILLIAM P · CIK 0001207928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,374

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2025.

F3 · balance_after: Includes 12,955 restricted stock units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:04 UTC
WALT DAVID RDirector
GrantCommon Stock 2,594 $5.54 $14,370.76
Disclosure

SEC source: 0001205236-25-000003 · primarydocument.xml · nonDerivative · entry 1

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,871,675

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2025.

F3 · balance_after: Includes 7,435 restricted stock units.

Read SEC document
October 01, 2025 Filed Oct 4, 2025 00:53 UTC
Mendel ScottDirector
GrantCommon Stock 2,084 $5.54 $11,545.36
Disclosure

SEC source: 0001515051-25-000003 · primarydocument.xml · nonDerivative · entry 1

Mendel Scott · CIK 0001515051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,737

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2025.

F3 · balance_after: Includes 24,464 restricted stock units.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 23:31 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 254 $5.43 $1,379.22
Disclosure

SEC source: 0001867276-25-000004 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512,938

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon vesting of 761 restricted stock units (RSUs).

F2 · balance_after: Includes 223,569 RSUs.

Read SEC document
September 15, 2025 Filed Sep 18, 2025 00:11 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $4.97 $1,138.13
Disclosure

SEC source: 0001908223-25-000006 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,971

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 777 Restricted Stock Units.

F2 · balance_after: Includes 71,670 Restricted Stock Units.

Read SEC document
September 15, 2025 Filed Sep 18, 2025 00:10 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $4.97 $6,172.74
Disclosure

SEC source: 0001867276-25-000003 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 513,192

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 3,722 RSUs.

F2 · balance_after: Includes 224,330 restricted stock units.

Read SEC document
September 12, 2025 Filed Sep 17, 2025 14:24 UTC
Sriram VandanaChief Financial Officer
PurchaseCommon Stock 4,150 $4.79 $19,878.50
Disclosure

SEC source: 0001908223-25-000005 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,200

F1 · balance_after: Includes 72,447 restricted stock units.

Read SEC document
August 31, 2025 Filed Sep 3, 2025 14:31 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 254 $4.55 $1,155.70
Disclosure

SEC source: 0001562180-25-006066 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 514,434

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 761 RSUs.

F2 · balance_after: Includes 228,052 restricted stock units.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:38 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $4.57 $1,046.53
Disclosure

SEC source: 0001562180-25-005891 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,050

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 777 RSUs.

F2 · balance_after: Includes 72,447 restricted stock units.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:36 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $4.57 $5,675.94
Disclosure

SEC source: 0001562180-25-005890 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 514,688

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 3,722 RSUs.

F2 · balance_after: Includes 228,813 restricted stock units.

Read SEC document
July 31, 2025 Filed Aug 4, 2025 20:03 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 254 $5.94 $1,508.76
Disclosure

SEC source: 0001562180-25-005615 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,930

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 761 RSUs.

F2 · balance_after: Includes 232,535 restricted stock units.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:37 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $5.49 $6,818.58
Disclosure

SEC source: 0001562180-25-005454 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 516,184

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 3,722 RSUs.

F2 · balance_after: Includes 233,296 restricted stock units.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:38 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $5.49 $1,257.21
Disclosure

SEC source: 0001562180-25-005455 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,279

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 777 RSUs.

F2 · balance_after: Includes 73,224 restricted stock units.

Read SEC document
July 08, 2025 Filed Jul 11, 2025 00:39 UTC GrantStock Option (right to buy) · Derivative 50,758 $0.00 Strike: $6.54 $0.00
Disclosure

SEC source: 0001562180-25-005380 · primarydocument.xml · derivative · entry 3

LAI GOLDMAN MYLA · CIK 0001168581 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,758

Underlying: Common Stock · 50,578 shares

Expires 2035-07-08

F4 · derivative.exercise_date: The option vests as to one-third of the shares on July 8, 2026, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments.

Read SEC document
July 08, 2025 Filed Jul 11, 2025 00:39 UTC GrantCommon Stock 24,464 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-005380 · primarydocument.xml · nonDerivative · entry 2

LAI GOLDMAN MYLA · CIK 0001168581 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,404

F2 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of the shares on each of July 8, 2026, July 8, 2027 and July 8, 2028.

F3 · balance_after: Includes 24,464 restricted stock units.

Read SEC document
July 08, 2025 Filed Jul 11, 2025 00:39 UTC GrantCommon Stock 2,940 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-25-005380 · primarydocument.xml · nonDerivative · entry 1

LAI GOLDMAN MYLA · CIK 0001168581 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,940

F1 · price: Received in exchange for 20,000 shares of Akoya Biosciences, Inc. ("Akoya") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Dr. Lai-Goldman received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share.

Read SEC document
July 08, 2025 Filed Jul 11, 2025 00:39 UTC
Mendel ScottDirector
GrantStock Option (right to buy) · Derivative 50,758 $0.00 Strike: $6.54 $0.00
Disclosure

SEC source: 0001562180-25-005379 · primarydocument.xml · derivative · entry 3

Mendel Scott · CIK 0001515051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,758

Underlying: Common Stock · 50,578 shares

Expires 2035-07-08

F4 · derivative.exercise_date: The option vests as to one-third of the shares on July 8, 2026, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments.

Read SEC document
July 08, 2025 Filed Jul 11, 2025 00:39 UTC
Mendel ScottDirector
GrantCommon Stock 24,464 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-005379 · primarydocument.xml · nonDerivative · entry 2

Mendel Scott · CIK 0001515051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,653

F2 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of the shares on each of July 8, 2026, July 8, 2027 and July 8, 2028.

F3 · balance_after: Includes 24,464 restricted stock units.

Read SEC document
July 08, 2025 Filed Jul 11, 2025 00:39 UTC
Mendel ScottDirector
GrantCommon Stock 4,189 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-25-005379 · primarydocument.xml · nonDerivative · entry 1

Mendel Scott · CIK 0001515051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,189

F1 · price: Received in exchange for 28,500 shares of Akoya Biosciences, Inc. ("Akoya") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Mr. Mendel received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 21:39 UTC GrantCommon Stock 2,242 $6.69 $14,998.98
Disclosure

SEC source: 0001562180-25-005256 · primarydocument.xml · nonDerivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309,279

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2025.

F3 · balance_after: Includes 7,435 restricted stock units.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 21:37 UTC GrantCommon Stock 4,204 $6.69 $28,124.76
Disclosure

SEC source: 0001562180-25-005253 · primarydocument.xml · nonDerivative · entry 1

DONNELLY WILLIAM P · CIK 0001207928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,298

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2025.

F3 · balance_after: Includes 12,955 restricted stock units.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 17:35 UTC
WALT DAVID RDirector
GrantCommon Stock 2,148 $6.69 $14,370.12
Disclosure

SEC source: 0001562180-25-005252 · primarydocument.xml · nonDerivative · entry 1

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,869,081

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2025.

F3 · balance_after: Includes 7,435 restricted stock units.

Read SEC document
July 01, 2025 Filed Jul 3, 2025 14:37 UTC GrantCommon Stock 2,615 $6.69 $17,494.35
Disclosure

SEC source: 0001562180-25-005307 · primarydocument.xml · nonDerivative · entry 1

Hlavinka Sarah E. · CIK 0001433554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,070

F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2025.

F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2025.

F3 · balance_after: Includes 7,435 restricted stock units.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:27 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 254 $6.65 $1,689.10
Disclosure

SEC source: 0001562180-25-005234 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 517,426

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 761 RSUs.

F2 · balance_after: Includes 237,018 restricted stock units.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 21:18 UTC
Toloue MasoudDirector · President & CEO
Tax withholdingCommon Stock 1,242 $6.06 $7,526.52
Disclosure

SEC source: 0001562180-25-004913 · primarydocument.xml · nonDerivative · entry 1

Toloue Masoud · CIK 0001867276 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 517,680

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 3,722 RSUs.

F2 · balance_after: Includes 241,779 restricted stock units.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 21:18 UTC
Sriram VandanaChief Financial Officer
Tax withholdingCommon Stock 229 $6.06 $1,387.74
Disclosure

SEC source: 0001562180-25-004912 · primarydocument.xml · nonDerivative · entry 1

Sriram Vandana · CIK 0001908223 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,508

F1 · shares: Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 777 RSUs.

F2 · balance_after: Includes 74,001 restricted stock units.

Read SEC document
June 13, 2025 Filed Jun 13, 2025 16:39 UTC
WALT DAVID RDirector
PurchaseCommon Stock 123,990 $6.14 $760,802.64
Disclosure

SEC source: 0001562180-25-004820 · primarydocument.xml · nonDerivative · entry 2

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,866,933

F3 · price: This transaction was executed in multiple trades at prices ranging from $5.96 to $6.235 The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes 7,435 restricted stock units.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 16:39 UTC
WALT DAVID RDirector
PurchaseCommon Stock 36,010 $6.23 $224,165.85
Disclosure

SEC source: 0001562180-25-004820 · primarydocument.xml · nonDerivative · entry 1

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,742,943

F1 · price: This transaction was executed in multiple trades at prices ranging from $6.17 to $6.31. The price reported reflects the weighted average purchase price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes 7,435 restricted stock units.

Read SEC document
June 09, 2025 Filed Jun 9, 2025 17:44 UTC
WALT DAVID RDirector
PurchaseCommon Stock 78,131 $5.34 $417,219.54
Disclosure

SEC source: 0001562180-25-004657 · primarydocument.xml · nonDerivative · entry 2

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,706,933

F3 · price: This transaction was executed in multiple trades at prices ranging from $5.08 to $5.59. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes 7,435 restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.